
360 ONE Quant Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Updated: 17 Sept 2026 • 12:40 pm
Posted by:

360 ONE Quant Fund Direct Growth Plan currently has a NAV of ₹19.4551 as of 16 September 2026 and scheme assets of ₹845 Cr. Its 1-year, 3-year and 5-year returns are -5.58%, 14.08% and 0%, respectively, and it sits in the High Risk category. Our view is that this is a fund for investors who can tolerate sharp swings and who are comfortable with a portfolio that is positioned more for active stock selection than for broad market tracking.
The recent return pattern is uneven, but the 3-year record is clearly better than the 1-year outcome. That makes it more suitable for investors who can stay invested through weaker stretches and judge the scheme over a longer holding period rather than through one short period alone.
Quick facts
| Particular | Details |
|---|---|
| NAV | ₹19.4551 as of 16 Sep 2026 |
| AUM | ₹845 Cr |
| Expense Ratio | 0.62% |
| Launch Date | 29 Nov 2021 |
| Min SIP | ₹1,000 |
| Risk Category | High Risk |
| Benchmark | Nifty 50 |
| Fund Category | Equity |
| Exit Load | 1% on or before 12M, Nil after 12M |
| Fund Managers | Pranav Mise, Viral Mehta |
The fund is managed by Pranav Mise and Viral Mehta.
Source data date: as of 16 Sep 2026
Performance
| Period | Fund return | Benchmark return |
|---|---|---|
| 1M | -4.9% | -4.41% |
| 3M | -0.5% | -3.6% |
| 1Y | -5.58% | -7.76% |
| 3Y | 14.08% | 5.74% |
| 5Y | Data not available | Data not available |
The fund has been weak over the most recent month and quarter, which tells us that near-term momentum is still fragile. Even so, the 3-month result is less negative than the benchmark, and the 1-year figure is also ahead of the benchmark’s 1-year outcome. That means the fund has held up better than Nifty 50 over the recent one-year stretch, even though both have been under pressure.
The longer view is more constructive. The 3-year return of 14.08% is materially stronger than the benchmark’s 5.74%, which suggests the strategy has added value over a fuller market cycle. The 5-year line is not available because the scheme launched in November 2021, so investors do not yet have a full five-year history to judge from.
The pattern across the time buckets is mixed rather than smooth. The daily path over the last three months and one year shows periods of drift, recovery and renewed weakness, so the fund does not behave like a steady defensive product. Our read-through is that investors are being paid for active positioning, but that positioning can also produce short stretches of underperformance.
For investors comparing it with the benchmark, the main point is that the fund’s edge is more visible over 3 years than over 1 year. That is important because it means the recent softness does not erase the stronger medium-term record, but it does remind investors that the ride can be uneven.
Source data date: as of 16 Sep 2026
Should you BUY or HOLD 360 ONE Quant?
A fund's past returns alone don't tell you whether you should buy it today or continue holding it.
The right decision depends on factors such as your current allocation, purchase price, risk profile, investment horizon and the role this fund plays in your overall portfolio.
Already holding 360 ONE Quant? Thinking of investing now?
Peer comparison
| Fund | 1Y return | 3Y return | 5Y return |
|---|---|---|---|
| 360 ONE Quant Fund Direct Growth Plan | -5.58% | 14.08% | Data not available |
| ICICI Pru Strategic Metal and Energy Equity FoF Direct Growth Plan | 69.8% | 36.32% | Data not available |
| HDFC Pharma and Healthcare Fund Direct Growth Plan | 25.31% | Data not available | Data not available |
| Kotak Healthcare Fund Direct Growth Plan | 25.27% | Data not available | Data not available |
| Motilal Oswal Active Momentum Fund Direct Growth Plan | 24.51% | Data not available | Data not available |
| PGIM India Healthcare Fund Direct Growth Plan | 22.75% | Data not available | Data not available |
This assessment is prepared by Uniapps Investment Adviser Pvt. Ltd. under SEBI Registered Investment Adviser registration INA000017639.
The fund’s 1-year return trails the strongest peer numbers in this set, and the gap is wide. Even so, the 3-year figure is stronger than every peer in this table with an available 3-year return, including the only peer that has both 1-year and 3-year numbers here. That creates a split picture: the shorter-term comparison is soft, while the medium-term comparison is more supportive.
Because most peer rows do not have 3-year or 5-year figures available, the table is most useful for one clear message: this fund has not matched the standout recent 1-year figures shown by several peers, but its 3-year record stands out more positively. The short-term and longer-term views therefore tell different stories, and the longer view is the more favourable one for this scheme.
Source data date: as of 16 Sep 2026
Want to know more? Log in to Univest for more mutual fund insights.
Portfolio: where your money goes
| Holding | Sector | Weight |
|---|---|---|
| Divi'S Laboratories Limited | Healthcare | 4.14% |
| TVS Motor Company Limited | Automobile & Ancillaries | 3.54% |
| Aurobindo Pharma Limited | Healthcare | 3.5% |
| Torrent Pharmaceuticals Limited | Healthcare | 3.44% |
| Bajaj Auto Limited | Automobile & Ancillaries | 3.43% |
| Cholamandalam Investment and Finance Company Ltd | Finance | 3.39% |
| Apl Apollo Tubes Limited | Iron & Steel | 3.32% |
| Polycab India Limited | Electricals | 3.31% |
| Titan Company Limited | Diamond & Jewellery | 3.29% |
| Bajaj Finance Limited | Finance | 3.21% |
The top 10 holdings account for approximately 34.57% of the portfolio.
To see all holdings, visit the 360 ONE Quant Fund Direct Growth Plan page
The single largest position, Divi’s Laboratories, is 4.14%, which is only modestly above the next few holdings rather than dominating the book. The gap from the first holding to the tenth is small in absolute terms, falling from 4.14% to 3.21%, so the visible portfolio is fairly tightly grouped at the top.
That said, the first 10 names together account for 34.57% across a total of 35 disclosed holdings, so the rest of the portfolio still matters. Our view is that this structure may reduce dependence on one or two positions, while still leaving several mid-sized holdings with meaningful influence.
The sector mix in the top holdings leans toward healthcare, automobiles, and finance, which may make performance more dependent on stock selection within these areas. Since the disclosed holdings extend well beyond the first 10, the scheme appears to use a reasonably long tail rather than concentrating the entire portfolio in a few bets.
Source data date: as of 16 Sep 2026
Who should invest
This fund suits investors with a high risk tolerance and a horizon long enough to look beyond month-to-month swings. The 1-year outcome is weak, but the 3-year record is stronger than the benchmark, so patience matters more here than quick performance chasing.
The main trade-off is that investors may have to accept a choppier ride in exchange for the possibility of better medium-term outcomes. That makes it more relevant for people who are comfortable with active equity exposure and can tolerate periods when the fund lags the market.
Tax and exit load
| Holding period | Tax rate | Description |
|---|---|---|
| Units held less than 1 year | 20% | Short-term capital gains tax |
| Units held more than 1 year | 12.5% | Long-term capital gains tax |
Exit load: 1% if units are sold within 12 months; no exit load after 12 months.
Source data date: as of 16 Sep 2026
Frequently asked questions
What is the current NAV of 360 ONE Quant Fund Direct Growth Plan?
The current NAV is ₹19.4551 as of 16 September 2026.
What are the fund’s 1-year, 3-year and 5-year returns?
The fund’s 1-year return is -5.58%, its 3-year return is 14.08%, and its 5-year return is 0 because the scheme does not yet have a full five-year history.
How has the fund performed versus the Nifty 50 benchmark?
It has done better than the benchmark over 1 year and 3 years, with 1-year return at -5.58% versus -7.76% for Nifty 50 and 3-year return at 14.08% versus 5.74% for Nifty 50. The recent 1-month and 3-month figures are still weak, so the short-term picture remains uneven.
Which peer fund in the comparison table has the strongest 1-year return?
ICICI Pru Strategic Metal and Energy Equity FoF Direct Growth Plan has the strongest 1-year return in the table at 69.8%. The rest of the comparison set also shows positive 1-year numbers, while this fund’s 1-year return is negative.
Is there a minimum SIP for this fund?
Yes, the minimum SIP amount is ₹1,000.
Who manages the fund and what is the exit load?
The fund is managed by Pranav Mise and Viral Mehta. The exit load is 1% if units are sold within 12 months, and there is no exit load after 12 months.
Bottom line
360 ONE Quant Fund Direct Growth Plan looks uneven in the short run but more credible over a longer holding period. Its recent performance is soft, yet the 3-year return is ahead of the benchmark and materially better than the short-term read. The portfolio is spread across 35 disclosed holdings, with the top 10 accounting for 34.57%, so it is not a one-position story. In our view, this is a High Risk equity fund better suited to investors who can stay invested through volatility.
Published on 17 September 2026 at 12:40 PM IST
Explore mutual funds with Univest
Review mutual fund data, compare performance and explore fund insights on Univest.
RIA disclosure
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. This review is prepared by Uniapps Investment Adviser Pvt. Ltd. (earlier known as Uniapps Global Research Pvt. Ltd.) under SEBI Registered Investment Adviser registration INA000017639 for general informational purposes and is not personalized investment advice.
Recent Articles

Mirae Asset Diversified Equity Allocator Passive FOF Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026

Bank of India Flexi Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026

Tata Multi Asset Allocation Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026

ITI Small Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Mirae Asset Diversified Equity Allocator Passive FOF Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Bank of India Flexi Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Tata Multi Asset Allocation Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
ITI Small Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Mirae Asset Overnight Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





